In this week’s Video Forum, Joe DePinto, head of cell, gene and advanced therapies at McKesson, talks about the company’s new InspiroGene division and the impact it is expected to have on the biotech marketplace. Precision dispensing and patient management, the product pipeline for advanced therapies, and recent research from InspiroGene were among the topics discussed.
Video Forum: Joe DePinto, McKesson
New division takes aim at cell and gene therapies.
Related
Coffee Chat: Craig Ford, LexisNexis
Craig Ford of LexisNexis discusses how actionable, cleaner data is reshaping pharmacy operations and patient care.
Latest
Padagis gets New York State Department of Health Naloxone contract
The agreement will expand access to the life-saving treatment while significantly lowering costs for taxpayers across the state.
NRF sees holiday sales surpassing $1 trillion
U.S. consumers are approaching the 2025 holiday season with caution but also confidence.
HDA Research Foundation announces 2025 Karen J. Ribler Supply Chain Scholars
Now in its seventh year, this annual scholarship is geared toward students pursuing any degree level or professional certification who work within HDA-member distributor and manufacturer companies.
Retail groups urge Congress to prevent penny shortage
Retailers across the US warn of escalating penny shortages, urging federal guidance and quick laws to avoid disrupting cash transactions.